Chiara Mercinelli: An honor to present Nure Combo trial at ASCO GU24

Chiara Mercinelli: An honor to present Nure Combo trial at ASCO GU24

Chiara Mercinelli, Fellow Research Oncology Resident IRCCS San Raffaele, posted on X/Twitter:

“It has been an honor to present today Nure Combo trial at ASCO GU24. Great results with neoadjuvant nivolumab/abraxane followed by adjuvant nivolumab in MIBC, with 38.7% ypT0N0.”

Image

Source: Chiara Mercinelli/X

 

ASCO bladder cancer cancer Chiara Mercinelli GU24 muscle invasive bladder cancer nivolumab/abraxane Nure Combo OncoDaily Oncology